tiprankstipranks
Trending News
More News >
Kymera Therapeutics (KYMR)
NASDAQ:KYMR
US Market
Advertisement

Kymera Therapeutics (KYMR) Technical Analysis

Compare
378 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Kymera Therapeutics’s (KYMR) Moving Averages Convergence Divergence (MACD) indicator is 1.71, suggesting Kymera Therapeutics is a Buy.
Kymera Therapeutics’s (KYMR) 20-Day exponential moving average is 59.20, while Kymera Therapeutics’s (KYMR) share price is $61, making it a Buy.
Kymera Therapeutics’s (KYMR) 50-Day exponential moving average is 54.98, while Kymera Therapeutics’s (KYMR) share price is $61, making it a Buy.

Kymera Therapeutics (KYMR) Pivot Points

Nov 08, 2025, 09:30 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
54.56
56.00
57.94
59.38
61.32
62.76
64.70
Fibonacci
56.00
57.29
58.09
59.38
60.67
61.47
62.76
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Kymera Therapeutics (KYMR) Moving Averages

Nov 08, 2025, 09:30 AM
Period
Simple
Exponential
MA5
60.47Buy
60.46Buy
MA10
60.52Buy
60.22Buy
MA20
59.81Buy
59.20Buy
MA50
53.85Buy
54.98Buy
MA100
48.91Buy
50.18Buy
MA200
41.35Buy
44.99Buy
Kymera Therapeutics’s (KYMR) 10-Day exponential moving average is 60.22, while Kymera Therapeutics’s (KYMR) share price is $61, making it a Buy.
Kymera Therapeutics’s (KYMR) 100-Day exponential moving average is 50.18, while Kymera Therapeutics’s (KYMR) share price is $61, making it a Buy.
Kymera Therapeutics’s (KYMR) stock price is $61 and Kymera Therapeutics’s (KYMR) 50-day simple moving average is 53.85, creating a Buy signal.
Kymera Therapeutics’s (KYMR) stock price is $61 and Kymera Therapeutics’s (KYMR) 100-day simple moving average is 48.91, creating a Buy signal.
Kymera Therapeutics’s (KYMR) stock price is $61 and Kymera Therapeutics’s (KYMR) 200-day simple moving average is 41.35, creating a Buy signal.

Kymera Therapeutics (KYMR) Technical Indicators

Nov 08, 2025, 09:30 AM
Name
Value
Implied Action
RSI (14)
58.06
Neutral
STOCH (9,6)
60.56
Neutral
STOCHRSI (14)
60.49
Neutral
MACD (12,26)
1.71
Buy
ADX (14)
24.63
Neutral
Williams %R
-29.14
Buy
CCI (14)
48.20
Neutral
ATR (14)
3.04
-
Ultimate Oscillator
60.95
Neutral
ROC
1.96
Buy
Kymera Therapeutics’s (KYMR) Relative Strength Index (RSI) is 58.06, creating a Neutral signal.
Kymera Therapeutics’s (KYMR) Trend Strength Indicator (ADX) is 24.63, creating a Neutral signal.
Kymera Therapeutics’s (KYMR) Commodity Channel Index (CCI) is 48.20, creating a Neutral signal.
Kymera Therapeutics’s (KYMR) Price Rate of Change (ROC) is 1.96, creating a Buy signal.

FAQ

Is KYMR a Buy, Hold, or Sell?
Based on KYMR’s technical indicators, KYMR is a Strong Buy.
    What is KYMR’s RSI (14)?
    KYMR’s RSI (14) is 58.06, which suggests KYMR is a Neutral.
      What is KYMR’s MACD?
      KYMR’s MACD is 1.71, which suggests KYMR is a Buy.
        What is KYMR’s 5-day moving average?
        KYMR’s 5-day moving average is 60.47, which suggests KYMR is a Buy.
          What is KYMR’s 20-day moving average?
          KYMR 20-day moving average is 59.81, which suggests KYMR is a Buy.
            What is KYMR’s 50-day moving average?
            KYMR’s 50-day moving average is 53.85, which suggests KYMR is a Buy.
              What is KYMR’s 200-day moving average?
              KYMR’s 200-day moving average is 41.35, which suggests KYMR is a Buy.
                What is KYMR’s Williams % R (14)?
                KYMR’s Williams % R (14) is -29.14, which suggests KYMR is a Buy.
                  What is KYMR’s CCI (14)?
                  KYMR’s CCI (14) is 48.20, which suggests KYMR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis